L. Peters

发表

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

A. Mocroft, C. Katlama, C. Toro, 2008, The Journal of infectious diseases.

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting

A. Mocroft, A. d’Arminio Monforte, H. Günthard, 2022, Open forum infectious diseases.

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.

A. Mocroft, V. Martel-Laferrière, M. Battegay, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology of hepatitis C virus in HIV-infected patients

M. Klein, L. Peters, 2015, Current opinion in HIV and AIDS.

Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

J. Neuhaus, J. Rockstroh, S. Bhagani, 2015, HIV medicine.

Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults

A. Mocroft, A. Szymczak, M. Bickel, 2012, PloS one.

Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting.

A. Mocroft, M. Johnson, J. Lundgren, 2020, Journal of acquired immune deficiency syndromes.

Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.

C. Leen, A. Mocroft, M. Laguno, 2020, AIDS.

Clinical outcomes in persons coinfected with HIV and HCV: Impact of HCV treatment

R. Haubrich, A. Mocroft, J. Lundgren, 2019, Clinical Infectious Diseases.

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.

R. Haubrich, A. Mocroft, J. Lundgren, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.

A. Antinori, A. De Luca, C. Mussini, 2017, Annals of internal medicine.

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study.

A. Mocroft, B. Clotet, V. Soriano, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is response to anti–hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients?

A. Cozzi-Lepri, L. Peters, 2016, AIDS.

A. Mocroft, O. Kirk, J. Lundgren, 2015, AIDS.

Establishing a hepatitis C continuum of care among HIV/hepatitis C virus‐coinfected individuals in EuroSIDA

C. Leen, A. Mocroft, A. d’Arminio Monforte, 2019, HIV medicine.

Biomarkers of fibrosis and impaired liver function in chronic hepatitis C: how well do they predict clinical outcomes?

J. Rockstroh, L. Peters, 2010, Current opinion in HIV and AIDS.

Five‐year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence

D. Valla, P. Batel, F. Pessione, 2003, Liver international : official journal of the International Association for the Study of the Liver.

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe.

A. Mocroft, F. Antunes, V. Soriano, 2010, The Journal of antimicrobial chemotherapy.

Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation.

J. Lundgren, S. Ostrowski, P. Johansson, 2018, Transplantation proceedings.

Observational cohort study of rilpivirine (RPV) utilization in Europe

C. Leen, A. Mocroft, R. Paredes, 2022, AIDS Research and Therapy.

Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection

A. Mocroft, H. Günthard, E. Bernasconi, 2022, Frontiers in Medicine.

Article Commentary: Is There a Need for Liver Disease Monitoring in HIV Patients in Africa?

J. Rockstroh, H. Wedemeyer, L. Peters, 2011, Antiviral therapy.

Liver disease is one of the leading causes of death in HIV-infected individuals from Europe and North Amer-

J. Rockstroh, L. Peters, H. Wedemeyer, 2011 .

Monitoring progress towards elimination of hepatitis B and C in the EU/EEA

M. Buti, M. Rosińska, T. Seyler, 2022, PLOS global public health.

Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

A. Mocroft, O. Kirk, D. Raben, 2021, HIV research & clinical practice.

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

S. Emery, C. Stephan, A. Arenas-Pinto, 2019, Hepatology.

The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

A. Mocroft, J. Lazarus, J. Lundgren, 2021, AIDS.

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.

A. Mocroft, A. d’Arminio Monforte, H. Günthard, 2022, The lancet. HIV.

Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons

A. Mocroft, J. Lundgren, M. Laguno, 2020, Open forum infectious diseases.

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

A. Mocroft, O. Kirk, J. Lundgren, 2014, AIDS.

Relapse of acute B viral hepatitis--role of delta agent.

S. Govindarajan, B. Valinluck, L. Peters, 1986, Gut.

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2021, The lancet. HIV.

The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

J. Lazarus, P. Schmid, M. van der Valk, 2022, AIDS.

Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

A. Mocroft, P. Reiss, J. Reekie, 2022, AIDS.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Tenofovir disoproxil fumarate withdrawal and cardiovascular risk – Authors' reply

A. Mocroft, L. Ryom, L. Peters, 2023, The Lancet HIV.

Hyaluronic Acid Levels Predict Increased Risk of Non-Aids Death in Hepatitis-Coinfected Persons Interrupting Antiretroviral Therapy in the Smart Study

A. Mocroft, B. Clotet, V. Soriano, 2011, Antiviral therapy.

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults

R. Bruno, C. Tural, V. Soriano, 2008, HIV medicine.

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey

A. Mocroft, J. Lazarus, M. Johnson, 2016, BMC Infectious Diseases.

Effect of Hepatitis C Treatment on Cd4+ T-C El L Counts And The Risk Of Death In HIV–HCV-Coinfected Patients: The Cohere Collaboration

B. Ledergerber, F. Dabis, A. Monforte, 2012, Antiviral therapy.

Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption

A. Mocroft, B. Clotet, J. Lundgren, 2010, AIDS.

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord

D. Raben, J. Rockstroh, F. Dabis, 2015, BMC Infectious Diseases.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

A. Mocroft, O. Kirk, V. Soriano, 2013, Journal of hepatology.

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

A. Mocroft, O. Kirk, V. Soriano, 2012, AIDS.

The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

A. Mocroft, J. Miro, M. Cavassini, 2021, HIV medicine.

Uptake of Tenofovir-Based Antiretroviral Therapy among HIV–HBV-Coinfected Patients in the EuroSIDA Study

A. Mocroft, J. Lundgren, J. Rockstroh, 2018, Antiviral therapy.

Clinical Society ( EACS ) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults

R. Bruno, C. Tural, V. Soriano, 2008 .

Hepatitis C Virus Coinfection Does Not Influence the CD4 Cell Recovery in HIV-1-Infected Patients With Maximum Virologic Suppression

A. Mocroft, V. Soriano, P. Reiss, 2009, Journal of acquired immune deficiency syndromes.

Hepatitis delta in HIV-infected individuals in Europe

C. Leen, F. Antunes, A. d’Arminio Monforte, 2011, AIDS.

Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.

E. Bernasconi, P. Reiss, J. Dufour, 2019, Journal of hepatology.

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*

A. Mocroft, O. Kirk, J. Lundgren, 2013, HIV medicine.

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA

Soriano, A. Mocroft, O. Kirk, 2012 .

Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam

O. Kirk, L. Peters, P. Phong, 2011, International journal of STD & AIDS.

Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps

A. Mocroft, O. Kirk, J. Lundgren, 2021, HIV medicine.

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective

A. Mocroft, O. Kirk, J. Lundgren, 2014, BMC Infectious Diseases.

Stability of hepatitis C virus (HCV) RNA levels among interferon‐naïve HIV/HCV‐coinfected individuals treated with combination antiretroviral therapy

A. Mocroft, O. Kirk, B. Ledergerber, 2013, HIV medicine.

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe

A. Mocroft, H. Stellbrink, J. Lundgren, 2021, HIV medicine.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

C. Leen, A. Mocroft, J. Gatell, 2018, AIDS.

High rate of hepatitis C virus (HCV) recurrence in HIV‐infected individuals with spontaneous HCV RNA clearance

A. Mocroft, J. Lundgren, C. Katlama, 2014, HIV medicine.

P. Vanhems, O. Kirk, R. Paredes, 2014 .

Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

Anders Karlsson, Jens D. Lundgren, Christian Pradier, 2013, PloS one.

Increases in acute hepatitis C (HCV) incidence across Europe: which regions and patient groups are affected?

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2012 .

Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV‐coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals

A. Mocroft, J. Rockstroh, C. Boesecke, 2017, HIV medicine.

HCV RNA profiles among chronic HIV/HCV coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in 9 individuals

A. Mocroft, J. Rockstroh, C. Boesecke, 2016 .

Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study

C. Leen, A. Mocroft, J. Lundgren, 2021, JAIDS Journal of Acquired Immune Deficiency Syndromes.

Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.

C. Leen, A. Mocroft, J. Lundgren, 2020, Journal of acquired immune deficiency syndromes.

[Sexual transmission of hepatitis C among HIV-positive men].

N. Weis, L. Peters, B. Lindhardt, 2006, Ugeskrift for laeger.

Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.

A. Mocroft, J. Lundgren, V. Vullo, 2019, AIDS.

MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year

A. Mocroft, J. Lundgren, A. Rasmussen, 2016, Scandinavian Journal of Gastroenterology.

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.

A. Mocroft, H. Günthard, J. Rockstroh, 2023, Journal of hepatology.

Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens

A. Mocroft, J. Reekie, M. Cavassini, 2022, AIDS.

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

A. Mocroft, A. d’Arminio Monforte, H. Günthard, 2022, AIDS.

Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients

J. Lundgren, J. Jensen, M. Bestle, 2019, Clinical chemistry and laboratory medicine.

Hyaluronic Acid Assays: Turbidimetric or Enzyme‐Based Immune Assay? A Method Comparison Study

J. Jensen, M. Bestle, N. Kirkby, 2016, Journal of clinical laboratory analysis.

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.

A. Mocroft, J. Lundgren, D. Duprez, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepatitis delta infection among persons living with HIV in Europe

A. Mocroft, H. Günthard, J. Rockstroh, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV.

R. Haubrich, C. Leen, A. Mocroft, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study

A. Mocroft, M. van der Valk, K. Kusejko, 2022, Open forum infectious diseases.

Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct‐acting antivirals—Results from the EuroSIDA study

C. Leen, A. Mocroft, A. Winston, 2022, HIV medicine.

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV

A. Mocroft, A. d’Arminio Monforte, C. Sabin, 2023, Cancers.